Aventis Defense Against Sanofi: Strong Pipeline Or Irrational “Exubera-nce”?

Aventis is using the prospects of Genasense as its first line of defense against Sanofi's hostile takeover bid

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet